Adverum Biotechnologies, Inc.
ADVM
Revenue
0.00
0.000.00%
3 Months ChangeAssets
253.80M
▼-14.03M▼-5.24%
3 Months ChangeLiabilities
85.77M
▲234.00k▲0.2736%
3 Months ChangeFree Cash Flow
-23.34M
▼-838.00k▼-3.72%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001628280-24-036769
2024-08-12
Form 8-K
ID: 0001628280-24-036763
2024-07-17
Form 8-K
ID: 0001193125-24-180412
2024-06-18
Form 8-K
ID: 0001193125-24-163397
2024-06-11
Form 8-K
ID: 0001193125-24-159134
2024-05-09
Form 10-Q
ID: 0001628280-24-022236
2024-05-09
Form 8-K
ID: 0001628280-24-022224
2024-03-20
Form 8-K
ID: 0001193125-24-072709
2024-03-18
Form 8-K
ID: 0001628280-24-011646
2024-02-08
Form 8-K
ID: 0001193125-24-027649